Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Dimopoulos: High serum lactate dehydrogenase level as a marker for drug resistance and short.... (0.10 sec) 

High serum lactate dehydrogenase level as a marker for drug resistance and short …


MA Dimopoulos, B Barlogie, TL Smith, R … - Annals of internal …, 1991 - Am Coll Physicians
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook
Add to Reddit Add to Technorati Add to Twitter What's this? ... Objective: To evaluate serum lactate
dehydrogenase (LDH) as a prognostic factor in previously untreated patients with multiple ...
Cited by 68 - Related articles - All 4 versions

High serum levels of lactic dehydrogenase identify a high-grade lymphoma-like …


B Barlogie, L Smallwood, T Smith, R … - Annals of internal …, 1989 - Am Coll Physicians
Although conferring a grave prognosis in patients with malignant lymphoma, high levels of serum
lactic dehydrogenase (LDH) are usually not seen in patients with multiple myeloma, a more indolent
tumor composed mainly of B cells in their terminal stage of differentiation. Thus, only 2 of ...
Cited by 94 - Related articles - All 4 versions

Plasma cell labeling index and beta 2-microglobulin predict survival independent …

- hematologylibrary.org [PDF] 
PR Greipp, JA Lust, WM O'fallon, JA … - …, 1993 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ...
Cited by 211 - Related articles - BL Direct - All 5 versions

High serum IL-2 levels are predictive of prolonged survival in multiple myeloma


G Cimino, G Avvisati, S Amadori, MC Cava, D … - Br J …, 1990 - interscience.wiley.com
Summary. In this study we analysed serum IL-2 levels in 61 patients with multiple myeloma
(MM). Patients serum IL-2 levels were significantly higher than normal controls. Moreover, higher
serum IL-2 levels were associated with a prolonged actuarial survival. In particular, 87% ...
Cited by 34 - Related articles - All 2 versions

C-reactive protein and beta-2 microglobulin produce a simple and powerful …

- bloodjournal.org [PDF] 
R Bataille, M Boccadoro, B Klein, B Durie, A Pileri - Blood, 1992 - Am Soc Hematology
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ...
Cited by 214 - Related articles - All 4 versions

Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a …

- bloodjournal.org [PDF] 
BG Durie, D Stock-Novack, SE Salmon, P Finley, J … - Blood, 1990 - Am Soc Hematology
REVIOUS REPORTS documented the usefulness of P serum & microglobulin levels for predicting
survival duration in patients with multiple Despite the many positive reports of the utility of serum
p2 microglobulin determinations, some investigators questioned the role of this marker in ...
Cited by 114 - Related articles - All 5 versions

Acute phase proteins and prognosis in multiple myeloma


G Merlini, V Perfetti, PG Gobbi, S Quaglini, … - British journal of …, 1993 - interscience.wiley.com
Serum IL-6 levels have been shown to correlate with disease severity and prognosis in patients
with plasma cell dyscrasias. Among its pleiotropic actions, IL-6 is also the major regulator of the
acute phase response in humans. The possible impact on survival of the major serum ...
Cited by 37 - Related articles - BL Direct - All 3 versions

A new staging system for multiple myeloma based on the number of S-phase …

- hematologylibrary.org [PDF] 
JF San Miguel, R Garcia-Sanz, M Gonzalez, … - …, 1995 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington
DC 20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print
ISSN 0006-4971, online ISSN 1528-0020), is published ... For personal use only. at ...
Cited by 115 - Related articles - BL Direct - All 5 versions

Plasmablastic Morphology---An Independent Prognostic Factor With Clinical and …

- hematologylibrary.org
PR Greipp, T Leong, JM Bennett, JP Gaillard, … - …, 1998 - bloodjournal.hematologylibrary.org
We studied the prognostic significance of plasmablastic (PB) multiple myeloma (MM) in Eastern
Cooperative Oncology Group Phase III trial E9486. Two reviewers independently reviewed 453
cases. They agreed on 37 PB (8.2%) cases and 416 non-PB cases, achieving an 85% ...
Cited by 95 - Related articles - BL Direct - All 7 versions

Myeloma protein kinetics following chemotherapy

- hematologylibrary.org [PDF] 
P McLaughlin, R Alexanian - Blood, 1982 - bloodjournal.hematologylibrary.org
. Hematology; all rights reserved Copyright 2007 by The American Society of DC 20036. by the
American Society of Hematology, 1900 M St, NW, Suite 200, Washington Blood (print ISSN
0006-4971, online ISSN 1528-0020), is published semimonthly ... For personal use only. ...
Cited by 67 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google